# NANOABLATION

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanoablation

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.r-ablation.com
- Latest round: Series B (Feb 11, 2025)
- Investors on record: 8

## About

Founded in 2014 and based in Hangzhou, China, NANOABLATION operates as a pulsed electric field technology provider that focuses on the application of electromagnetic technology in tumor treatment. Its production and R&D base is located in Hangzhou Future Technology Park. It acquired ISO13485 quality management system certification. It established the Provincial Key Laboratory of Pulsed Electric Field Technology Medical Transformation with the First Affiliated Hospital of Zhejiang University School of Medicine. The company has applied for nearly 200 patents and has PCT patents for the European and American markets. It has been recognized as Zhejiang Specialized, Refined, Featured and Original SMEs, Hangzhou Quasi-Unicorn Enterprise and Hangzhou Enterprise High-tech R&D Center. In February 2025, NANOABLATION closed a series B+ funding.

The company is mainly engaged in the research and development of electromagnetic tumor therapy. Products include nanosecond pulse tumor ablation system, digital psychological behavior assessment platform system, tumor treatment device, minimally invasive puncture electrode and other supporting medical devices. It has developed multiple product pipelines for tumors, atrial fibrillation, chronic brain diseases, etc.

The company generates revenue by providing pulse tumor ablation system, digital psychological behavior assessment platform system and other supporting medical devices.

The company will use the funds to advance the clinical trials and commercialization of a number of products developed based on the nanosecond pulsed electric field technology platform.

## Funding rounds

- Series B, Feb 11, 2025 — Zhangjiang Haoheng Capital
- Series B, Oct 17, 2021 — Jifeng Ventures, Taikun Fund, Anjie Investment, Xinzhaoyuan Capital, Hangzhou Xiaochi Private Equity Fund Management
- Series A, Feb 18, 2019 — Proxima Ventures, Zhejiang Sanjie Investment Management
- Series A, Jul 24, 2018 — Proxima Ventures

## Investors

- Proxima Ventures (https://capitalatlas.ai/funds/proxima-ventures) — Series A
- Zhejiang Sanjie Investment Management — Series A
- Jifeng Ventures (https://capitalatlas.ai/funds/jifeng-ventures) — Series B
- Taikun Fund — Series B
- Anjie Investment — Series B
- Xinzhaoyuan Capital — Series B
- Hangzhou Xiaochi Private Equity Fund Management (https://capitalatlas.ai/funds/hangzhou-xiaochi-private-equity-fund-management) — Series B
- Zhangjiang Haoheng Capital (https://capitalatlas.ai/funds/zhangjiang-haoheng-capital) — Series B